Atherosclerosis Flashcards

1
Q

What are the layers of the arterial wall?

A

Intima – single layer of endothelial cells

Media – consists of smooth muscle and extracellular matrix, and subserve the contractile and elastic function of the vessel. It is separated by elastin layers.

Adventitia – contain the nerve, lymphatic and blood vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does normal endothelial cells work as anti-thrombin molecules?

A

Normal endothelial cells process anti-thrombin molecules. Some reside on the endothelial surface (heparan sulfate, thrombomodulin and plasminogen activator), while other products enter the circulation (e.g., prostaglandin I2 and nitric oxide (NO)). Endothelial cells secret substance (such as vasodilator and vasoconstrictors) that modulate the underlying muscle layer to alter the resistance and the luminal blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do vascular smooth muscle cells produce?

A

Collagen, elastic and proteoglycans which forms the vascular extracellular matrix. They also can synthesize vasoactive and inflammatory mediators (such as IL-6 and TNF-α).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does the extracellular matrix of the artery made of? What is its function?

A

Fibrillar collagen, proteoglycan, and elastin make up most of the extracellular matrix, and they are responsible for the strength and flexibility of the arteries. The extracellular matrix regulated the growth of its resident cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the stages mechanism of atherosclerotic lesion?

A

Fatty streak
Plaque progression
Plaque disruption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the mechanism for fatty streaks production!

A

Endothelial dysfunction allows the entry and modification of lipids within the subendoteliala space. Lipids within the endothelial space serve as proinflammatory mediators that initiate leukocytes recruitment and foam cells formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain endothelial dysfunction role in atherosclerosis!

A

Injury (due to physical force or chemical irritants) to the arterial endothelium represents a primary event in atherogenesis. In straight sections of arteries, the normal laminar shear forces favor the endothelial production of NO. Laminar flow increase the expression of the antioxidant enzyme superoxide dismutase, which protects against reactive oxygen species produced by chemical irritants or transient ischemia. However, disturbed flow occurs at arterial branch point.
Endothelial dysfunction my result from tobacco smoking, abnormal circulating lipid level and diabetes. These risk factors increase the production of reactive oxygen species (superoxide anion) that interact with intracellular molecules. In such an environment, the cells promote local inflammation. This interrupt the endothelial role as a permeability barrier and alter the release of vasoactive substance and interfere with normal anti-thrombotic properties.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the mechanism of lipoprotein entry to the intima and modification!

A

Increased endothelial permeability allows the entry of low density lipoprotein (LDL) into the intima, a process facilitated by an elevated circulating LDL concentration. On the other hand, several monogenic causes of elevated LDL exist, including mutations in the LDL receptor, apolipoprotein B, and PCSK9 (a protease involved in regulation of the LDL receptor). Once within the intima, the LDL pound to the proteoglycans. Hypertension may promote retention of lipoproteins in the intima by accentuating the production of LDL-binding proteoglycans by smooth muscle cells.
The reactive oxygen species and pro-oxidant enzyme derived from endothelial or smooth muscle cell or from macrophages oxides the LDL that are trapper in the subendothelial cells. The microenvironment of the subendothelial space can isolated oxidized LDL from anti-oxidants in the plasma. In diabetic patients with sustained hyperglycemia, glycation of the LDL can occur – a modification that can provide the LDL antigenic and pro-inflammatory.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does hypertension promote retention of lipoproteins in intima?

A

intima by accentuating the production of LDL-binding proteoglycans by smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the mechanism for leukocytes recruitment!

A

Recruitment depends on the expression of LAM (ICAM-1 and selectin) on normally non-adherent endothelial cells, and on chemoattractant signals (e.g., monocytes chemotactic protein 1 (MCP-1), IL-8, interferon-inducible protein 10).
mLDL (modified LDL) can induce LAM, chemoattractant cytokine and stimulates endothelial and smooth muscle cells to produce pro-inflammatory cytokine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the mechanism for foam cell formation!

A

The macrophages engulf the mLDL with their scavenger receptors that bind and neutralize mLDL. mLDL ingested by scavenger receptor evades negative feedback inhibition and permits swelling of the macrophages with cholesterol and cholesteryl ester, resulting in foam cells. The accumulation of lipid, stress the macrophages and cause them to go apoptosis. The lipid-rich center of a plaque, formed by necrotic foam cells, is called necrotic core.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain plaque progression! Both the early plaque growth and late plaque growth!

A

The atherosclerotic plaque acquires a distinct thrombogenic lipid core that underlies a protective fibrous cap. Early plaque growth shows a compensatory outward remodeling of the arterial wall that preserves the diameter of the lumen and permits the plaque accumulation without the limitation of the blood flow. Later plaque growth can outstrip the compensatory arterial enlargement, restrict the vessel lumen, and impede perfusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain the mechanism for smooth muscle cell migration

A

The transition of the fatty streak to fibrous atheromatous plaque involves the migration of smooth muscle for media into the intima, proliferation of the smooth muscle within the intima, and secretion of extracellular matrix. The endothelial cells elaborate signal smooth muscle cell migration and proliferation. Foam cells produce factors that contribute to smooth muscle cell recruitment. For example, they release platelet-derived growth factor (PDGF) which stimulate the migration of smooth muscle cells across the internal elastic lamina and into the subintimal space, where they can replicate. PDGF stimulates the growth of residual smooth muscle cells in the intima. Foam cells also release cytokines and growth factors (TNF-α, IL-1, fibroblast growth factor, and TGF-β) that urge smooth muscle cell proliferation and synthesis of extracellular matrix proteins.
The plaque growth is punctuated by subclinical events with bursts of smooth muscle replication. Small breaches in the plaque integrity can expose tissue factor from foam cells, which activate coagulation and microthrombus formation. Activated within such microthrombi release potent factors (including PDGF and heparinase) that can spur a local wave of smooth muscle cell migration and proliferation. Heparinase degrades heparan sulfate (which normally inhibits smooth muscle cells migration and proliferation).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain how extracellular matrix metabolism is effected! What factors stimulate/inhibit collagen production?

A

Smooth muscle cells favor fortification of the fibrous cap. Net matrix deposition depends on the balance of synthesis by smooth muscle cells and degradation, mediated in part by a class of proteolytic enzymes know as matrix metalloproteinase (MMP). PDGF and TGF-β stimulate smooth muscle cell production of interstitial collagens. While INF-γ inhibit smooth muscle cell collagen synthesize. Inflammatory cytokines stimulate local foam cells to secrete collagen- and elastin degrading MMP, thereby weakening the fibrous cap and predisposing it to rupture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What determine plaque integrity?

A

The size of the lipid core has the biomechanical implications for the stability of the plaque. With increasing size and protrusion into the arterial lumen, mechanical stress focuses on the plaque border abutting normal tissue. In addition to bearing stress, local accumulation of foam cells and T lymphocytes at this site accelerates degradation of extracellular matrix, making this region the most common site of plaque rupture. Plaques that have thinner caps tend to be fragile, and more likely to rupture and incite thrombosis. Clinical terminology describes the spectrum of integrity as “Stable plaques” (marked by a thick fibrous cap and small lipid core) or “vulnerable plaques” (marked by a thin fibrous cap, rich lipid core, extensive macrophages infiltrate, and a little amount of smooth muscle).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can a plaque have thrombogenic potential? What are factors that affect person’s propensity toward coagulation?

A

Small non-occlusive thrombi may reabsorb into the plaque, stimulating smooth muscle growth and fibrous deposition. The probability of a major thrombotic events reflects the balance between the competing processes of coagulation and fibrinolysis. Inflammatory stimuli common in the plaque microenvironment elicit tissue factor from many plaque component, including smooth muscle cells, endothelial cells, and macrophages-derived foam cells. Inflammatory stimuli support thrombosis by favoring the expression of antifibrinolytic (plasminogen activator inhibitory-1) over the expression of anticoagulants (thrombomodulin, heparin-like molecules, protein S) and profibrinolytic mediators (tissue plasminogen activator and urokinase-type plasminogen activator).

A person’s propensity toward coagulation may be enhanced by genetic (e.g., the presence of a procoagulant prothrombin gene mutation), comorbid condition (e.g., diabetes), and/or lifestyle factors (e.g., smoking, visceral obesity).

17
Q

What are the complications of atherosclerosis?

A
  • Calcification of the atherosclerotic plaque which increase the vessel fragility.
  • Rupture of the plaque which exposes procoagulants within the plaque to circulating blood, causing a thrombus to form at the site.
  • Hemorrhage into the plaque owing to rupture of the fibrous cap or of the microvessels that form within the lesion.
  • Embolization
  • Weakening of the vessel wall: the fibrous plaque subjects the media layer to increased pressure, which may provoke atrophy and loss of elastic tissue with expansion of the arteries, forming an aneurysm.
  • Microvessels growth within plaques, providing a source for intraplaque hemorrhages and further leukocyte trafficking.
18
Q

What are atherosclerosis risk factors?

A

Risk factors include high levels of circulating lipids, tobacco smoking hypertension, diabetes mellitus, and lack of physical activity and obesity. Major nonmodifiable risk factors include advanced age, male sex, and heredity. Other biological markers include elevated circulating levels of the amino acid metabolite homocysteine, the special lipoprotein particle Lp(a), and certain markers of inflammation (CRP).

19
Q

How does dyslipidemia lead to atherosclerosis? What is the role of HDL?

A

Saturated fat and prevalent hypercholesterolemia causes coronary diseases. The risk of ischemic heart disease increases with higher total serum cholesterol levels. When LDL is present in excess, it can accumulate in the subendothelial space and undergo the chemical modification that further damages the intima. Conversely, elevated high-density lipoprotein (HDL) particle appear to protect against atherosclerosis, likely because of HDL’s ability to transport cholesterol away from the peripheral tissue back to the liver for disposal and because of its antioxidative and anti-inflammatory properties.
Elevated serum LDL may persist for many reasons, including a high-fat diet or abnormalities in the LDL-receptor clearance mechanism. Genetic defects in the LDL receptor, which lead to a condition known familial hypercholesterolemia, can’t remove LDL from the circulation efficiently.
Very low-density lipoprotein VLDL and intermediate-density lipoprotein LDL, in the development of atherosclerosis.

20
Q

What are lipid-altering therapy?

A

Lifestyle alternation

Diet [replacement of saturated fats with polyunsaturated fats (particularly α-linolenic acid, and omega-3 fatty acid)] and exercise comprise two important components of the risk reduction arsenal.
The polyunsaturated fats increase the expression of the major HDL apoprotein (apo AI) and the enzymes lipoprotein lipase and inhibits cytokine-induced expression of LAM on endothelial cells. Physical activity and loss of excess weight can improve the lipid profile, by lowering TAG and raising HDL.

Pharmacology
The major group of lipid-altering agents include HMG-CoA reductase inhibitors (statin), niacin, fibric acid derivative, cholesterol intestinal absorption inhibitors and bile acid-binding agents. Statin inhibit the rate-limiting enzyme responsible for cholesterol biosynthesis. The resulting reduction in intracellular cholesterol concertation promotes increased LDL-receptor expression and augmented clearance of LDL particles from the bloodstream. Statin also lower the rate of VLDL synthesis in the liver (by lowering circulating TAG) and raise HDL. Statin also reduce the plasma levels of CRP.
Other beneficial action includes increased NO synthesis, enhance fibrinolytic activity, inhibition of smooth muscle proliferation and monocytes recruitment, and reduction in macrophages production of matrix-degrading enzymes.

21
Q

How does statin work

A

Statin inhibit the rate-limiting enzyme responsible for cholesterol biosynthesis. The resulting reduction in intracellular cholesterol concertation promotes increased LDL-receptor expression and augmented clearance of LDL particles from the bloodstream. Statin also lower the rate of VLDL synthesis in the liver (by lowering circulating TAG) and raise HDL. Statin also reduce the plasma levels of CRP.

22
Q

How does tobacco smoking increases the risk for atherosclerosis?

A

Tobacco smoking could lead to atherosclerotic disease in several ways, including enhance oxidative modification of LDL, decreased circulating HDL levels, endothelial dysfunction owing to tissue hypoxia and increased expression of soluble LAM, stimulation of the sympathetic nervous system by nicotine, and displacement of oxygen by CO from hemoglobin.

23
Q

How does diabetes mellitus and metabolic syndrome increases the risk for atherosclerosis?

A

The predisposition of diabetic patient to atherosclerosis may relate in part to the non-enzymatic glycation of lipoprotein (which enhance uptake the of cholesterol by scavenger receptor). Diabetic frequently have impaired endothelial function, gauged by reduce bioavailability of NO and increased leukocytes

24
Q

How does hypertension increases the risk for atherosclerosis?

A

Elevated blood pressure injures to vascular endothelium and may increase the permeability of the vessel wall to lipoproteins. Increased hemodynamic stress can augment the number of scavenger on macrophages, thus enhancing the development of foam cells. Increased in hypertensive arteries can enhance smooth muscle cell production of proteoglycans that bind and retain LDL particles, promoting their accumulation in the intima and facilitating their oxidative modification. Angiotensin II act as vasoconstrictor and a stimulator of oxidative stress (through activation of NADPH oxidases, a source of superoxide anion) and proinflammatory cytokines. Diet with fruit and vegetable, with dietary products low in fat and a reduced sodium content improves systolic and diastolic blood pressure.

25
Q

How does lack of exercise increase the risk for atherosclerosis?

A

Exercise enhance insulin sensitivity and endothelial production of NO.

26
Q

How does estrogen increase the risk for atherosclerosis?

A

Estrogen have atheroprotective properties. Physiologic estrogen levels in premenopausal woman raise HDL and lower LDL. However, estrogen-plus-progestin treatment increased cardiovascular.

27
Q

How does homocysteine increase the risk for atherosclerosis? Which supplement can be used to decrease its serum concentration?

A

Abnormal levels promote oxidative stress, vascular inflammation, and platelet adhesiveness. Although folic acid and other vitamin B supplement reduce high serum homocysteine levels.

28
Q

How does C-reactive protein and markers of inflammation increases the risk for atherosclerosis?

A

(IL-6) mobilize to the liver and incite increased production of acute-phase reactants, including CRP, fibrinogen, and serum amyloid A.

29
Q

What do lipoproteins consist of? What is the function of Apoproteins

A

Lipoproteins particles consist of lipid core surrounded by more hydrophilic phospholipid, free cholesterol, and apoproteins.

30
Q

What is the function of Apoproteins

A

Apoproteins serve as the “conductors” of the system, directing the lipoproteins to specific tissue receptor and mediating enzymatic reactions.

31
Q

What are the major types of lipoproteins

A

There are five major lipoproteins, chylomicrons, very low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL).

32
Q

What are the pathways of lipoproteins in body-?

A

1- Fats are absorbed by the small intestine and repackages as chylomicrons.
2- Apo E and subtypes of apo C are transferred to chylomicrons from HDL particles in the bloodstream.
3- Apo C enhances interactions of chylomicrons with lipoprotein lipase (LPL) on the endothelial surface of adipose and muscle tissue. This reaction hydrolyzes the triglycerides within chylomicrons into free fatty acids (FFA), which are stored by adipose tissue or used for energy in cardiac and skeletal muscle.
4- Chylomicron remnants are removed from the circulation by the liver, mediated by apo E.
5- One fate of cholesterol in the liver is incorporation into bile acids, which are exported to the intestine, completing the exogenous pathway cycle.

6- The liver packages cholesterol and triglycerides into VLDL particles, accompanied by apo B-100 and phospholipid. The triglyceride content of VLDL is much higher than that of cholesterol, but this is the main means by which the liver releases cholesterol into the circulation.
7- VLDL is catabolized by LPL, releasing fatty acids to muscle and adipose tissue. During this process, VLDL also interacts with HDL, exchanging some of its triglyceride for apo C subtypes, apo E, and cholesteryl ester from HDL. The latter exchange is mediated by cholesteryl ester transfer protein (CETP).
8- Approximately 50% of the VLDL remnants (termed intermediate-density lipoproteins [IDL]) are then cleared in the liver by hepatic receptors that recognize apo E.